News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease
Mike Thompson/LinkedIn
Oct 27, 2024, 17:41

Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease

Mike Thompson, Vice President of Clinical Partnerships at Tempus AI, shared on X:

“S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease to direct Therapy Duration (DRAMMATIC) – Amrita Krishnan, Hoering, Phari, Sexton, Robert Z. Orlowski.

ASH20 Abstract 1515

1515 Phase III Study of Daratumumab/rhuph20 (nsc- 810307) + Lenalidomide or Lenalidomide As Post-Autologous Stem Cell Transplant Maintenance Therapyin Patients with Multiple Myeloma (mm) Using Minimal Residual Disease Todirect Therapy Duration (DRAMMATIC study): SWOG s1803

Authors: Amrita Krishnan, Antje Hoering, Parameswaran Hari, Rachael Sexton, Robert Z. Orlowski

Mike Thompson: Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease

Amrita Krishnan Antje Hoering cancer Mike Thompson Myeloma OncoDaily Oncology Parameswaran Hari Rachael Sexton Robert Z. Orlowski
Special Coverage
Blog
Jan 30, 2025, 09:16
Esranur Aydın: Some cases change the way we think about treatment
Blog
Jan 30, 2025, 09:14
Pashtoon Kasi: Treatment Strategies for Liver Metastases - Insights from a GI25 Study
Science
Jan 30, 2025, 09:11
Anthracycline-induced cardiomyopathy: risk prediction, prevention and treatment
Blog
Jan 30, 2025, 09:08
Ossama Shaheen: We proudly stand with BGICC, hand in hand
Blog
Jan 30, 2025, 09:04
Strengthening disease prevention through clean air measures - Association of European Cancer Leagues
Blog
Jan 30, 2025, 09:02
Mayar Moner: BGICC 2025 allowed me to network with brilliant minds from the scientific community
Blog
Jan 30, 2025, 09:00
Esosa Omoregie: Quantitative PCR machine to quantify Aquaporin 10
Blog
Jan 30, 2025, 08:57
Sophie Bussmann-Kemdjo: From Nigeria to the world
Blog
Jan 30, 2025, 08:55
Aleix Prat: Unlocking the potential of engineered immune cell therapy for solid tumors
Blog
Jan 30, 2025, 08:53
Karen Merritt: Hoping for labelling updates to recommend pre-treatment DPD deficiency testing
Blog
Jan 30, 2025, 08:46
Latest updates in surgery, radiation oncology, and medical oncology at BGICC - SPCC
Science
Jan 30, 2025, 08:44
Final analysis of the PRECIOUS phase 3 trial